Inventor · disambiguated record
Yong Yea Park
Also filed as: PARK YONG KUN · PARK YONG YEA
1 granted patent·3 pending applications·1 citations·filing 2001–2022
17Inventor score
Top patents by PatentIndex Score
4 records- 0170US11401343B2Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising sameGREEN CROSS CORP·Filed 2018·Granted Aug 2, 2022·1 cites·13 claims
- 0251US2024140944A1Novel naphthyridinone derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase and use thereofTXINNO BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0350US2024116882A1Novel benzotriazole derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase, and use thereofTXINNO BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 0438US2004057908A1Oral compositions and use thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yong Yea Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →